Regarding response to Yamaguchi et al’s “Anti-SS-A antibody is a potential predictor of severe Stevens–Johnson syndrome and toxic epidermal necrolysis: A retrospective cohort study” - 19/02/25
Doi : 10.1016/j.jaad.2024.11.030
Yuko Watanabe, MD, PhD, Yukie Yamaguchi, MD, PhD ⁎ 
Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
∗Correspondence to: Yukie Yamaguchi, MD, PhD, Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, JapanDepartment of Environmental Immuno-DermatologyYokohama City University Graduate School of Medicine3-9 FukuuraKanazawa-kuYokohama236-0004Japan
Key words : anti-SS-A antibody, drug reactions, lupus, Stevens-Johnson syndrome/toxic epidermal necrolysis
Le texte complet de cet article est disponible en PDF.
| Funding sources: This study was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (Y.W.), and by AMED under Grant Number 22mk0101173h1402 (Y.Y.). |
|
| Patient consent: The study was conducted using the opt-out method from our hospital website. |
|
| IRB approval status: The study was approved by the Yokohama City University Ethics Committee (approval no: B210300039). |
|
| Data availability statements: The data sets generated and/or analyzed during the current study are available from the corresponding author upon reasonable request. |
© 2024
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 92 - N° 3
P. e73-e74 - mars 2025 Retour au numéro
Article précédent
- Response to Yamaguchi et al “Anti-SS-A antibody is a potential predictor of severe Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective cohort study”
- Sweta Subhadarshani, Taylor Griffith
- Insufficient evidence for association between dermatology follow-up and melanoma survival
- Jue Tang, Hao-Ran Cheng
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?